|
LRRC42 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8867000000089E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02259999999566E-05 |
| Normal-vs-Stage2 |
4.156100E-03 |
| Normal-vs-Stage3 |
1.037350E-04 |
| Normal-vs-Stage4 |
1.84699999961069E-07 |
| Stage1-vs-Stage2 |
7.617800E-01 |
| Stage1-vs-Stage3 |
9.939400E-01 |
| Stage1-vs-Stage4 |
2.200100E-02 |
| Stage2-vs-Stage3 |
7.779800E-01 |
| Stage2-vs-Stage4 |
7.943700E-02 |
| Stage3-vs-Stage4 |
4.748300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.23669999999521E-05 |
| Normal-vs-AfricanAmerican |
4.796100E-02 |
| Normal-vs-Asian |
1.417899999967E-06 |
| Caucasian-vs-AfricanAmerican |
5.726000E-01 |
| Caucasian-vs-Asian |
2.631900E-02 |
| AfricanAmerican-vs-Asian |
5.901800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.649070E-04 |
| Normal-vs-Female |
1.53380000000869E-06 |
| Male-vs-Female |
8.632000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.181140E-04 |
| Normal-vs-Age(41-60Yrs) |
4.39399999996315E-06 |
| Normal-vs-Age(61-80Yrs) |
2.09299999999191E-05 |
| Normal-vs-Age(81-100Yrs) |
7.638400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.843200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.758200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.984200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.619600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.695800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.994600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.317200E-01 |
| Classical-VS-Follicular |
1.828640E-01 |
| Classical-VS-Other |
5.933000E-01 |
| Classical-VS-Normal |
6.02979999999587E-05 |
| Tall-VS-Follicular |
9.709200E-01 |
| Tall-VS-Other |
9.750400E-01 |
| Tall-VS-Normal |
2.047300E-04 |
| Follicular-VS-Other |
9.835200E-01 |
| Follicular-VS-Normal |
1.155810E-04 |
| Other-VS-Normal |
6.368500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.52809999999626E-05 |
| Normal-vs-N1 |
1.04609999995731E-07 |
| N0-vs-N1 |
2.512400E-02 |
|
|
